References from Abstract No: 521 Efficacy and Safety of Tofacitinib Monotherapy for Primary IgA Nephropathy with Persistent Proteinuria. Local targets link to admitted publications; unresolved targets remain external evidence.
No reference evidence is available for this admitted work.
References for Abstract No: 521 Efficacy and Safety of Tofacitinib Monotherapy for Primary IgA Nephropathy with Persistent Proteinuria | ResearchHub - ResearchHub
